Aparna EG¹, Biji Bahuleyan¹, Sanu J Vincent¹ and Ashalatha Radhakrishnan²*

¹Comprehensive Epilepsy Care Centre, Medical Trust Hospital, Ernakulam, Kerala, India
²Professor and Head, Comprehensive Epilepsy Care Centre, Medical Trust Hospital, Ernakulam, Kerala, India

*Corresponding Author: Ashalatha Radhakrishnan, Professor and Head, Comprehensive Epilepsy Care Centre, Medical Trust Hospital, Ernakulam, Kerala, India.

Received: July 24, 2023; Published: September 20, 2023

Abstract

In this report, we describe the case of a 21-year-old man with epilepsy, presenting with obsessive compulsive disorder (OCD) and tics while on levetiracetam monotherapy. Diagnosis of tics in a person with epilepsy (PWE) is challenging and after a detailed evaluation, possibility of drug induced tics was considered. Both symptoms abated on stopping Levetiracetam therapy. Levetiracetam induced various behavioral side effects have been reported in both adult and pediatric patients, but OCD and tics are extremely rare and not known to many. The unique mechanism of action of Levetiracetam has been proposed as the possible explanation for these behavioral manifestations. At the same time there is literature evidence for use of Levetiracetam in Tics. We wish to emphasize on this double edged sword nature and give further insights into it.

Keywords: Tics; OCD; Epilepsy

References

1. American Psychiatric Association. “Diagnostic and Statistical Manual of Mental Disorders: DSM-5”. Washington, DC: American psychiatric association 5.5 (2013).
2. Baibing Chen and Kamil Detyniecki. “Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy”. Neurology16 (2017): S34.
3. FikretPoyrazÇökmüş., et al. “Relationship of levetiracetam and obsessive-compulsive disorder: a case report”. Psychiatry and Clinical Psychopharmacology3 (2017): 319-321.
4. Fujikawa M., et al. “Obsessive-Compulsive Behavior Induced by Levetiracetam”. Journal of Child Neurology7 (2021):942-944.
5. Peters J., et al. “Tics induced by antiepileptic drugs: a pragmatic review”. Journal of Neurology 268(2021): 321-336.
6. , et al. “Glutamatergic augmentation strategies in obsessive-compulsive disorder”. Indian Journal of Psychiatry 61.1 (2019): S58-S65.
7. Rosenberg DR., et al. “Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls”. Journal of the American Academy of Child and Adolescent Psychiatry 43 (2004):1146-1153.
8. Wright C., et al. “Clinical pharmacology and pharmacokinetics of levetiracetam”. Frontiers in Neurology 4 (2013): 192.
9. Wang HR., et al. “Potential role of anticonvulsants in the treatment of obsessive-compulsive and related disorders”. Psychiatry and Clinical Neurosciences 10 (2014): 723-732.
10. Awaad Y., et al. “Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome”. Movement Disorders 20 (2005): 714-718.

Citation

Citation: Ashalatha Radhakrishnan., et al. “Tics, OCD and Epilepsy: To Lump or Split?". Acta Scientific Neurology 6.10 (2023): 14-16.

Copyright

Copyright: © 2023 Ashalatha Radhakrishnan., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.